RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
VMFGX
Price
$454.79
Change
-$2.62 (-0.57%)
Updated
Sep 20 closing price
Ad is loading...

RPTIX vs VMFGX

Header iconRPTIX vs VMFGX Comparison
Open Charts RPTIX vs VMFGXBanner chart's image
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
Vanguard S&P Mid-Cap 400 Growth Idx I
Price$454.79
Change-$2.62 (-0.57%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RPTIX vs VMFGX Comparison Chart
Loading...
VS
RPTIX vs. VMFGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPTIX is a StrongBuy and VMFGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. VMFGX (1.23B). VMFGX pays higher dividends than RPTIX: VMFGX (1.05) vs RPTIX (0.18). RPTIX was incepted earlier than VMFGX: RPTIX (9 years) vs VMFGX (13 years). VMFGX is a more actively managed with annual turnover of: 48.00 vs. RPTIX (21.70). RPTIX has a lower initial minimum investment than VMFGX: RPTIX (500000) vs VMFGX (5000000). VMFGX annual gain was more profitable for investors over the last year : 26.81 vs. RPTIX (14.81). VMFGX return over 5 years is better than : 63.13 vs. RPTIX (15.09).
RPTIXVMFGXRPTIX / VMFGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years13 years-
Gain YTD9.12716.25556%
Front LoadN/AN/A-
Min. Initial Investment500000500000010%
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B1.23B2,551%
Annual Yield % from dividends0.181.0517%
Returns for 1 year14.8126.8155%
Returns for 3 years-13.5714.87-91%
Returns for 5 years15.0963.1324%
Returns for 10 yearsN/A147.62-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp